Roche going back to biotech bank
Executive Summary
Swiss company has registered an additional 17.3 mil. Genentech shares, worth $3.3 bil. at current prices. Roche has already raised $5.8 bil. from two Genentech stock offerings and a bond issue since it exercised its $3.7 bil. buyout option on Genentech in June